Health Care & Life Sciences » Pharmaceuticals | Polydex Pharmaceuticals Ltd.

Polydex Pharmaceuticals Ltd.

Polydex Pharmaceuticals Ltd.
Stock Exchange Other OTC
EPS
$0.07
Market Cap
$3.72 M
Shares Outstanding
3.38 M
Public Float
-

Profile

Address
421 Comstock Road
Toronto Ontario M1L 2H5
Canada
Employees -
Website http://www.polydex.com
Updated 07/08/2019
Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. If focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals.

Financials

View All
Created with Highcharts 5.0.14Polydex Pharmaceuticals Ltd.Net Income. Fiscal year is February-January. All values USD Thousands.6586585785781 2771 2776696694484482302302014201520162017201820190250500750100012501500
Created with Highcharts 5.0.14Polydex Pharmaceuticals Ltd.Sales/Revenue. Fiscal year is February-January. All values USD Thousands.5 9635 9635 3765 3766 0406 0406 6216 6215 2795 2794 9424 94220142015201620172018201902k4k6k8k

George G. Usher
Chairman, President & Chief Executive Officer
Joseph Buchman
Director